Erratum to: TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors (Journal of Clinical Immunology DOI: 10.1007/s10875-010-9456-8);TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors

Journal of Clinical Immunology

Volumn 31, Issue 1, 2011, Pages 89-98

  Agrawal, Sudhanshu ^a   Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD25; CD80; CD86; chemokines; cytokines; memory B cell; Naive B cell

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD27 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79953892799     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9471-9     Document Type: Erratum

References (36)

1. Fillatreau S, Gray D, Anderson SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008;8:391-6.
2. Hoehlig K, Lampropoulou V, Roch T, Neves P, Calderon-Gomez E, Anderton SM, et al. Immune regulation by B cells and antibodies a view towards the clinic. Adv Immunol. 2008;98:1-38.
3. Lund FE. Cytokine-producing B lymphocytes - key regulator of immunity. Curr Opin Immunol. 2008;20:332-8.
4. Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005;25:29-40. (Pubitemid 40386176)
5. Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705-10. (Pubitemid 43099663)
6. Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cells signals CD40 ligand, interferon ã, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med. 1999;189:1-11. (Pubitemid 29047022)
7. Barr TA, Brown S, Ryan G, Zhao J, Gray D. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007;37:3040-53. (Pubitemid 350131284)
8. Gray D, Gray M, Barr T. Innate responses of B cells. Eur J Immunol. 2007;37:3304-10.
9. Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006;36:810-6.
10. Duddy M, Niino M, Adatia F, Herbert S, Freedman M, Atkins H, et al. Distinct effector cytokine profile of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178:6092-9. (Pubitemid 46717389)
11. Gargo A, Servis D, Cepika AM, Toellner KM, Grafton G, Taylor DR, et al. Type I cytokine profile of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology. 2006;118:66-77.
12. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, et al. IL12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol. 2004;172:854-963.
13. Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol. 2002;21:335-76.
14. Kawai T, Akira S. TLR signaling. Sem Immunol. 2007;19:24-32. (Pubitemid 46498752)
15. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005;560:11-8.
16. Dasari P, Nicholson IC, Hodge G, Dandie GW, Zola H. Expression of toll-like receptors on B cells. Cell Immunol. 2005;236:140-5.
17. Mansson A, Adner M, Hockerfelt C, Cardell L-O. A distinct toll-like receptor repertoire in human tonsil B cells, directly activated by Pam3CSK4, R-837 and Cpg-200 stimuation. Immunology. 2006;118:539-48. (Pubitemid 44079572)
18. Cognasse F, Hamzeh-Cogness H, Lafarge S, Chavarin P, Pozzeto B, Richard Y, et al. Identification of two subppulations of purified human Blood B cells, CD27-CD23+ and CD27highCD80+, that strongly express cell surface toll-like receptor 9 and secrete high levels of interleukin-6. Immunology. 2008;125:430-7.
19. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531-7. (Pubitemid 34441357)
20. Pistota V. Production of cytokines by human B cells in health and diseases. Immunol Today. 1997;18:343-50.
21. Krieg AM, Yi AK, Matson S, Waldscmidt TJ, Bishop GA, Teasdale R, et al. CpG motif in bacterial DNA trigger direct B cell activation. Nature. 1995;374:546-9.
22. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol. 2007;37:2205-13. (Pubitemid 47250213)
23. Borsutzky S, Kreschmer K, Becker PD, Muhlradt PF, Kirsching CJ, Weiss S, et al. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J Immunol. 2005;174:6308-13. (Pubitemid 40663823)
24. Bekeredjian-Ding I, Inamura S, Giese T, Moll H, Endres S, Sing A, et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol. 2007;178:2803-12. (Pubitemid 46333158)
25. Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol. 2005;174:4043-50. (Pubitemid 40395980)
26. Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol. 2009;2(3):265-75.
27. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19+CD24hiCD38hi exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129-40.
28. Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M. IFN-α amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol. 2009;86:261-71.
29. Hanten JA, Vasilakos JP, Riter CI, Neys L, Lipson KE, Alkan SS, et al. Comparision of human B cell activation by TLR7 and TLR9. BMC Immunol. 2008;9:39.
30. Zhang X, Deriaud E, Jiao X, Braun D, LeClerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin-10 producing B cells. J Exp Med. 2007;204:1107-18. (Pubitemid 46798154)
31. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084-97. (Pubitemid 18024248)
32. Lupardus PJ, Birnbaum ME, Garcia KC. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure. 2010;18:332-42.
33. Lee EY, Lee Z-H, Song YW. CXCL10 and autimmune diseases. Autoimmun Rev. 2009;8:379-83.
34. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348-57.
35. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein 1. Cytokine Growth Factor Rev. 2002;13:455-81.
36. Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5:554-9.